Yangli Pharma closes nine-figure RMB Series B round led by Qiming Venture Partners
Focused on developing first-in-class and best-in-class Class 1 innovative drugs with global intellectual property rights, with a focus on oncology and chronic disease therapeutics.
Qiming Venture Partners' Portfolio Company WeRide, a Global Pioneer in L4 Autonomous Driving, Completes Dual Primary Listing on Hong Kong Exchanges and Clearing Limited
WeRide is the Chinese autonomous driving company with the broadest international footprint and the most comprehensive product portfolio, and it is also the only technology company in the world whose products hold autonomous driving permits in seven countries.
Qiming Healthcare Partnering Day 2025 Successfully Held in Shanghai, Fostering Partnerships Between Global Pharma Giants and Chinese Biotech Startups
This marks the fourth consecutive year that Qiming Venture Partners has hosted this event, which to date has facilitated hundreds of one-on-one meetings for over a hundred leading global pharmaceutical and investment companies, laying a solid foundation for expanding the scope and elevating the level of collaboration between enterprises.
Qiming Star | Changsen Pharma Raises Hundreds of Millions of Yuan in Series B+ Funding to Accelerate Clinical Research and Global Expansion of Core Pipeline
Changsen Pharma is dedicated to independently developing first-in-class, best-in-class innovative drugs with global intellectual property rights to address unmet clinical needs.
"Private funds raise capital only from specific qualified investors who meet certain criteria." Qiming Venture Partners reminds all investors and entrepreneurs to stay vigilant, verify authenticity, and avoid financial losses.
Qiming Venture Partners Portfolio Companies Make 2025 Beijing Top 100 Private Enterprise Rankings
The list aims to highlight trends in Beijing's private-sector economy and industrial distribution, identify a cohort of high-quality private enterprises that align with the "high-end, precision, and cutting-edge" economic structure and demonstrate leading, exemplary, and driving effects, and encourage and guide private enterprises in practicing new development concepts to promote high-quality growth.